arrow_back Back to App

Increased Funding for Pediatric Cancer Research

This act aims to ensure that a fair percentage of federal cancer research funds are dedicated to pediatric cancer research. This means more money will be directed towards finding better treatments and prevention methods for a disease affecting the youngest. As a result, parents and children battling cancer can hope for faster medical advancements.
Key points
The act mandates that, starting from fiscal year 2022, the percentage of federal cancer research funds allocated to pediatric cancer research must match the percentage of children in the U.S. population.
Increased funding for pediatric cancer research could lead to new discoveries, improved therapies, and potentially higher cure rates for young patients.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2210
Sponsor: Rep. Fitzpatrick, Brian K. [R-PA-1]
Process start date: 2021-03-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Fairness to Kids with Cancer Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2210.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-26.

What are the main provisions?

Key points include:

  • The act mandates that, starting from fiscal year 2022, the percentage of federal cancer research funds allocated to pediatric cancer research must match the percentage of children in the U.S. population.
  • Increased funding for pediatric cancer research could lead to new discoveries, improved therapies, and potentially higher cure rates for young patients.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Fitzpatrick, Brian K. [R-PA-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health